• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nanalysis announces support from Wiley for NMR Instruments in KnowItAll 2026

    10/7/25 5:00:00 PM ET
    $WLY
    Books
    Consumer Discretionary
    Get the next $WLY alert in real time by email

    CALGARY, AB, Oct. 7, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV:NSCI) (OTCQX:NSCIF) (FRA: 1N1), a leader in portable Nuclear Magnetic Resonance (NMR) instruments and Magnetic Resonance Imaging (MRI) technology for industrial and research applications, announced new file support from Wiley, a global leader in authoritative content and research intelligence, in their KnowItAll 2026 software release for raw NMR files.

    This integration enables KnowItAll users to incorporate low-field NMR data analysis into their analytical workflows, further extending the software's multi-technique approach. At the same time, Nanalysis users can now easily integrate KnowItAll's complete suite of NMR analysis tools into their workflow, including raw spectral data processing, database building, prediction, searching, and direct access to Wiley's comprehensive NMR data collections* for streamlined compound identification.

    Wiley's KnowItAll NMR database collection currently contains over 1.28 million 1D spectra for 1H-NMR, 13C-NMR, and X-NMR (11B, 15N, 17O, 19F, 29Si, 31P), with additional add-on collections available.

    Nanalysis 1D NMR files can now be imported into KnowItAll 2026 providing access to over 1.28 million NMR spectra for database searching.* (CNW Group/Nanalysis Scientific Corp.)

    "We're pleased to add native support for Nanalysis NMR files in KnowItAll 2026. This new file compatibility reflects Wiley's ongoing effort to support diverse analytical laboratory workflows and instrument manufacturers," said Graeme Whitley, Senior Director, Data Science Solutions at Wiley.

    "In the pursuit of democratizing NMR, it is crucial to add software layers that can simplify spectral interpretation and help include it in routine laboratory analysis workflows for customers in pharmaceuticals, biotechnology, materials, polymers etc.  To this end, we are pleased to partner with Wiley's KnowItAll to ensure that our users have access to their state-of-the-art database and searching algorithms." said Dr. Susanne Riegel, VP Marketing and Product Management at Nanalysis.

    Learn more about Wiley's KnowItAll Software and Spectral Libraries at https://sciencesolutions.wiley.com. 

    Wiley's KnowItAll provides a unified manufacturer-neutral software solution to identify, analyze, and manage analytical data across multiple techniques (IR, GC-MS, LC-MS, NMR, Raman, UV-Vis). Powered by Wiley's comprehensive, high-quality spectral reference libraries and advanced search algorithms, KnowItAll delivers fast, reliable spectral analysis that streamlines laboratory workflows and drives actionable results for confident decision making.

    *subscription required

    About Wiley

    Wiley (NYSE:WLY) is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.

    About Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1))

    Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company also operates a growing services division that maintains both its own products and third-party imaging equipment, anchored by a $160 million long-term contract with the Canadian Air Transport Security Authority (CATSA) to maintain security scanners at more than 80 Canadian airports.

    Nanalysis Scientific Corp. Logo (CNW Group/Nanalysis Scientific Corp.)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-support-from-wiley-for-nmr-instruments-in-knowitall-2026-302577502.html

    SOURCE Nanalysis Scientific Corp.

    Get the next $WLY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WLY

    DatePrice TargetRatingAnalyst
    9/8/2022Market Perform → Market Outperform
    CJS Securities
    8/29/2022Market Outperform → Market Perform
    CJS Securities
    More analyst ratings

    $WLY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Wiley Increases Fiscal 2026 Share Repurchase Allocation to $100 million

    Company recently reported strong Q2 margin expansion and reaffirmed full year earnings and free cash flow guidance Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that it has boosted its Fiscal 2026 share repurchase allocation to $100 million, up from $60 million in Fiscal 2025 and $45 million in Fiscal 2024. Wiley has already executed approximately $35 million of this allocation in the first half with an objective of executing $65 million through the rest of the fiscal year ending April 30, 2026. In the first half, the Company raised its quarterly dividend for the 32

    12/10/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Research Growth, AI Momentum, and Margin Expansion Highlight Wiley's Second Quarter 2026

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025. SECOND QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $422 million vs. $427 million including foregone revenue of $3 million from divested businesses; Operating Income of $73 million up 14%; and Diluted Earnings Per Share (EPS) of $0.84 up 14% Adjusted Results at constant currency: Adjusted Revenue of $422 million down 1% with solid Research growth more than offset by market-related declines in Learning; Adjusted Operating Income of $79 million up 14%

    12/4/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Schedules Second Quarter 2026 Earnings Release and Conference Call

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its second quarter 2026 results prior to market open on Thursday, December 4, 2025. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606 US and Canada callers, please dial (888) 210-3346 and enter the participant code 2521217#. Or International callers, please dial (646) 960-0253 and enter the participant code 2521217#. ABOUT WILEY Wiley (NYSE:WLY) is a gl

    11/26/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    $WLY
    SEC Filings

    View All

    $WLY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $WLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $WLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    John Wiley & Sons Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/10/25 11:21:47 AM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 10-Q filed by John Wiley & Sons Inc.

    10-Q - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/5/25 9:40:56 AM ET
    $WLY
    Books
    Consumer Discretionary

    John Wiley & Sons Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - JOHN WILEY & SONS, INC. (0000107140) (Filer)

    12/4/25 11:00:14 AM ET
    $WLY
    Books
    Consumer Discretionary

    Kissner Matthew S bought $502,028 worth of Class A Common (16,550 units at $30.33), increasing direct ownership by 181% to 25,705 units (SEC Form 4)

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/19/23 6:04:59 PM ET
    $WLY
    Books
    Consumer Discretionary

    Dobson David C bought $152,357 worth of Class A Common (5,081 units at $29.99), increasing direct ownership by 64% to 13,033 units (SEC Form 4) (Amendment)

    4/A - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/19/23 2:50:35 PM ET
    $WLY
    Books
    Consumer Discretionary

    Dobson David C bought $152,357 worth of Class A Common (5,081 units at $29.99), increasing direct ownership by 64% to 13,033 units (SEC Form 4)

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/18/23 4:30:50 PM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 4 filed by Director Singh Inder M

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:48:29 PM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 4 filed by Director Mcdaniel Raymond W

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:47:08 PM ET
    $WLY
    Books
    Consumer Discretionary

    SEC Form 4 filed by Director Madden Karen N

    4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)

    10/24/25 1:45:44 PM ET
    $WLY
    Books
    Consumer Discretionary

    Wiley upgraded by CJS Securities

    CJS Securities upgraded Wiley from Market Perform to Market Outperform

    9/8/22 9:07:27 AM ET
    $WLY
    Books
    Consumer Discretionary

    Wiley downgraded by CJS Securities

    CJS Securities downgraded Wiley from Market Outperform to Market Perform

    8/29/22 10:00:26 AM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    Leadership Updates

    Live Leadership Updates

    View All

    Wiley Appoints Katya Andresen to Board of Directors

    Chief Digital & Analytics Officer for The Cigna Group has strong background in technology and AI innovation Wiley (NYSE:WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Katya Andresen, chief digital & analytics officer for The Cigna Group, to its Board of Directors. Andresen's background spans technology, data, analytics, and AI innovation across Fortune 500 companies and emerging enterprises. She has led significant initiatives at The Cigna Group and Capital One and successfully transformed Cricket Media by launching a profitable data and digital licensing business. "As we continue to advance our priorities

    6/30/25 8:00:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Appoints Craig Albright as Executive Vice President and Chief Financial Officer

    Seasoned finance executive brings a proven track record in driving profitable growth, improving operational efficiency, and optimizing cash flow Wiley (NYSE:WLY), one of the world's largest publishers and a global leader in research and education, today announced the appointment of Craig Albright as executive vice president and chief financial officer, effective June 26, 2025. Chris Caridi, who has led Wiley's finance organization as interim chief financial officer, will continue with the role of senior vice president, chief accounting officer and finance transformation leader. Albright joins Wiley with over 30 years of global leadership expertise in finance, strategy, and consulting ro

    6/23/25 8:00:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley appoints Karen N. Madden, Ph.D., to its Board of Directors

    MilliporeSigma Chief Technology Officer Brings Extensive Science, Technology, and Innovation Leadership Experience Wiley (NYSE:WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is Senior Vice President and Chief Technology Officer at MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. At MilliporeSigma, Madden shapes the Technology Roadmap and long-term R&D strategy, systematically exploring emerging opportunities that lead to breakthrough innovations. She leads the Life Science Innovation Board, ensuring a balance o

    3/5/25 8:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    $WLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    11/8/24 3:02:29 PM ET
    $WLY
    Books
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    10/23/24 5:04:46 PM ET
    $WLY
    Books
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by John Wiley & Sons Inc.

    SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)

    10/18/24 8:42:58 AM ET
    $WLY
    Books
    Consumer Discretionary

    $WLY
    Financials

    Live finance-specific insights

    View All

    Wiley Increases Fiscal 2026 Share Repurchase Allocation to $100 million

    Company recently reported strong Q2 margin expansion and reaffirmed full year earnings and free cash flow guidance Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that it has boosted its Fiscal 2026 share repurchase allocation to $100 million, up from $60 million in Fiscal 2025 and $45 million in Fiscal 2024. Wiley has already executed approximately $35 million of this allocation in the first half with an objective of executing $65 million through the rest of the fiscal year ending April 30, 2026. In the first half, the Company raised its quarterly dividend for the 32

    12/10/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Research Growth, AI Momentum, and Margin Expansion Highlight Wiley's Second Quarter 2026

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025. SECOND QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $422 million vs. $427 million including foregone revenue of $3 million from divested businesses; Operating Income of $73 million up 14%; and Diluted Earnings Per Share (EPS) of $0.84 up 14% Adjusted Results at constant currency: Adjusted Revenue of $422 million down 1% with solid Research growth more than offset by market-related declines in Learning; Adjusted Operating Income of $79 million up 14%

    12/4/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary

    Wiley Schedules Second Quarter 2026 Earnings Release and Conference Call

    Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its second quarter 2026 results prior to market open on Thursday, December 4, 2025. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606 US and Canada callers, please dial (888) 210-3346 and enter the participant code 2521217#. Or International callers, please dial (646) 960-0253 and enter the participant code 2521217#. ABOUT WILEY Wiley (NYSE:WLY) is a gl

    11/26/25 7:30:00 AM ET
    $WLY
    $WLYB
    Books
    Consumer Discretionary